- Home
- IRBT vs ZURA Comparison
IRBT vs ZURA Comparison
Compare IRBT & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRBT
- ZURA
- Stock Information
- Founded
- IRBT 1990
- ZURA 2022
- Country
- IRBT United States
- ZURA United States
- Employees
- IRBT N/A
- ZURA N/A
- Industry
- IRBT Consumer Electronics/Appliances
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IRBT Consumer Discretionary
- ZURA Health Care
- Exchange
- IRBT Nasdaq
- ZURA Nasdaq
- Market Cap
- IRBT 168.4M
- ZURA 137.2M
- IPO Year
- IRBT N/A
- ZURA N/A
- Fundamental
- Price
- IRBT $4.63
- ZURA $3.35
- Analyst Decision
- IRBT Hold
- ZURA Buy
- Analyst Count
- IRBT 1
- ZURA 9
- Target Price
- IRBT N/A
- ZURA $11.00
- AVG Volume (30 Days)
- IRBT 3.2M
- ZURA 4.3M
- Earning Date
- IRBT 11-04-2025
- ZURA 11-06-2025
- Dividend Yield
- IRBT N/A
- ZURA N/A
- EPS Growth
- IRBT N/A
- ZURA N/A
- EPS
- IRBT N/A
- ZURA N/A
- Revenue
- IRBT $594,601,000.00
- ZURA N/A
- Revenue This Year
- IRBT N/A
- ZURA N/A
- Revenue Next Year
- IRBT $69.39
- ZURA N/A
- P/E Ratio
- IRBT N/A
- ZURA N/A
- Revenue Growth
- IRBT N/A
- ZURA N/A
- 52 Week Low
- IRBT $1.76
- ZURA $0.97
- 52 Week High
- IRBT $13.06
- ZURA $5.07
- Technical
- Relative Strength Index (RSI)
- IRBT 57.47
- ZURA 56.31
- Support Level
- IRBT $4.36
- ZURA $3.18
- Resistance Level
- IRBT $6.10
- ZURA $4.58
- Average True Range (ATR)
- IRBT 0.53
- ZURA 0.35
- MACD
- IRBT 0.07
- ZURA -0.05
- Stochastic Oscillator
- IRBT 42.72
- ZURA 52.17
About IRBT iRobot Corporation
iRobot Corp is a United state based consumer robot company. It designs and builds robots that assist consumers with the solutions for the activities to be carried out both inside and outside of the home. The company's consumer robot comprises a portfolio of solutions which includes cleaning, mapping and navigation, human-robot interaction, and physical solutions. The company operates in the business segment of Consumer robots. The consumer robot products are provided to the consumers by retail businesses and online stores. The company derives its revenue from the product sales. It sells the products across the United States and around the world.
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.